news
Taro Pharmaceuticals voluntarily recalls one lot of lamotrigine tablets
Due to cross-contamination with enalapril maleate, Taro is voluntarily recalling one lot of its lamotrigine tablets at the consumer level.
List view / Grid view
Epilepsy
news
Epidyolex available to patients through the NHS from today
Epidyolex, which contains cannabidiol, can now be prescribed by doctors to epilepsy patients in the UK through the NHS.
news
Medicinal cannabis product granted approval in Ireland
A medicinal CBD oil has been approved for importation, prescription and supply under the Medical Cannabis Access Programme (MCAP) in Ireland.
news
Anti-epileptic drug XCOPRI® approved by the FDA
Based on results from two global randomised studies and a large open-label safety study, XCOPRI has been approved by the FDA as a treatment for partial-onset seizures in adults.
news
Leaked document reveals ‘unprecedented’ medicine shortages in NHS
A document from the DHSC has reportedly advised NHS doctors to ration certain medicines after outlining dozens of drugs that are in shortage, as published in a report.
news
NICE to work with GW Pharma on cannabidiol evaluation
NICE and GW Pharma will work together to address the issues highlighted in its evaluation of cannabidiol for treating two types of epilepsy.
news
NICE releases draft guidance for using cannabis-based medicinal products
The NICE and NHS have announced their draft recommendations for the prescribed use of cannabis-based treatments.
news
No association between antiepileptic drug use and dementia
Antiepileptic drugs have been found to have no association with dementia, with researchers looking at the data of over 50,000 patients...
news
Generic version of seizure drug Sabril gets FDA approval
A generic version of the seizure drug Sabril (vigabatrin) has been approved by the FDA...
news
Medical cannabis made available on prescription in the UK
Medical cannabis is now avaliable through the NHS, but many are warning about its drawbacks and that it won't be available for those who need it...
news
Growth of medical cannabis market after approvals and clinical trials
A report has suggested that growth of medical cannabis will reach between $11.9 and $17.1 billion by 2020, and is currently around $5 to $6 billion...
news
Seizures could be stopped and prevented with implanted electronic device
Researchers have developed an electronic device which could help to detect, prevent and stop seizures from occurring in epileptic patients...
news
CBD significantly reduces seizures in patients with severe epilepsy
Cannabidiol was shown in a new large-scale, randomised, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy...
news
FDA approves Briviact for partial-onset seizures in paediatric epilepsy
The approval provides paediatric epilepsy patients a treatment option which can be initiated at a therapeutic dose from day one...
news
CBD may help curb frequency of epileptic seizures
A naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures...
